Facilitated By

San Antonio Medical Foundation

News

  • Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a ...

    ... San Antonio Breast Cancer Symposium. Share. SAN DIEGO, Calif.--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology ...

  • Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer ...

    ... San Antonio Breast Cancer Symposium ("SABCS"), in San Antonio, TX being held at the Henry B. Gonzalez Conven.

  • Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical ...

    ... San Antonio Breast Cancer Symposium ... Tags. Io Therapeutics · Irx4204 · Car-t · Breast Cancer · Biotechnology ...

  • Tivic acquires cGMP assets, secures $90M+ growth financing | TIVC Stock News

    ... biotech customers. The company validated the Entolimod cell line at ... San Antonio. Velocity Bioworks focuses on rapidly advancing biologic ...

  • Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate ...

    Creates new revenue opportunities for Tivic via Velocity Bioworks' ability to serve other biotech companies. ... San Antonio. Velocity Bioworks focuses ...